Dr Reddy's launches Esomeprazole Magnesium Delayed-release Capsules

Dr. Reddy’s ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES USP, 20 mg and 40 mg are available in bottle count size of 30.

Dr. Reddy’s Laboratories announced that it has launched ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES USP, 20 mg and 40 mg, a therapeutic equivalent generic version of NEXIUM  (esomeprazole magnesium) Delayed-Release Capsules in the US market on September 25, 2015, following the approval by the United States Food & Drug Administration (USFDA).

The NEXIUM (esomeprazole magnesium) Delayed-Release Capsules brand and generic had U.S. sales of approximately $5.2 Billion MAT for the most recent twelve months ending in July 2015 according to IMS Health.

Dr. Reddy’s ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES USP, 20 mg and 40 mg are available in bottle count size of 30.

The stock is currently trading at Rs. 4184, up by 212.35 points or 5.35% from its previous closing of Rs. 3971.65 on the BSE.

The scrip opened at Rs. 3921 and has touched a high and low of Rs. 4222.75 and Rs. 3921 respectively. So far 64834(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 67751.79 crore.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4337 on  and a 52 week low of Rs. 2883.4 on . Last one week high and low of the scrip stood at Rs. 4040 and Rs. 3855.65 respectively.

The promoters holding in the company stood at 25.48 % while Institutions and Non-Institutions held 43.67 % and 13.81 % respectively.

The stock is currently trading below its 50 DMA.